A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia

This study has been completed.

Study NCT00350467 Information provided by Xian-Janssen Pharmaceutical Ltd.

First Received: July 7, 2006 Last Updated: May 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2007
Estimated Primary Completion Date:	No date given